Morgan Stanley Finance LLC Files 424B2 Prospectus for New Securities

TL;DR

**Morgan Stanley Finance LLC just filed a prospectus for new securities, likely debt, under its existing shelf registration.**

AI Summary

Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, filed a 424B2 prospectus on March 24, 2026, related to its existing shelf registration statement (File No. 333-275587-01). This filing indicates that Morgan Stanley Finance LLC is offering new securities, likely debt instruments, under its previously approved registration. For investors, this means Morgan Stanley Finance LLC is raising capital, which could impact its financial leverage and future earnings, making it important to understand the terms of these new securities.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new securities to raise capital, which could affect its debt levels and financial health, directly impacting the parent company Morgan Stanley's overall risk profile and future profitability.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the underlying offering of new securities introduces financial risk depending on the terms and use of proceeds.

Analyst Insight

Investors should review the full pricing supplement (PRICING SUPPLEMENT NO. 14,935) to understand the specific terms, interest rates, and maturity dates of the new securities being offered by Morgan Stanley Finance LLC, as these details will impact the company's financial obligations and potential returns.

Key Numbers

• 0001666268 — CIK of Morgan Stanley Finance LLC (Unique identifier for the filing entity)
• 0000895421 — CIK of Morgan Stanley (Unique identifier for the parent company)
• 333-275587-01 — File No. for Morgan Stanley Finance LLC (Identifies the specific registration statement this prospectus supplements)
• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed with the SEC)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
• Morgan Stanley (company) — Parent company of the filer
• 333-275587-01 (dollar_amount) — File number for the shelf registration statement
• 2026-03-24 (dollar_amount) — Filing date of the 424B2 prospectus

Forward-Looking Statements

• Morgan Stanley Finance LLC will successfully issue new securities under the terms of this prospectus. (Morgan Stanley Finance LLC) — high confidence, target: 2026-06-30

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $2,000,000 — below) Aggregate principal amount: $2,000,000 Underlier: MSCI EAFE Index (the "un
• $966.80 — Estimated value on the pricing date: $966.80 per security. See "Estimated Value of t
• $0 — eds to us (2) Per security $1,000 $0 $1,000 Total $2,000,000 $0 $2
• $6 — will receive a structuring fee of up to $6 for each security from the agent or its
• $1,128 — change Maximum payment at maturity: $1,128 per security (112.80% of the stated pri
• $1,050 — appreciates 5%, investors will receive $1,050 per security, or 105% of the stated pri
• $250 — 75% of their principal and receive only $250 per security at maturity, or 25% of the

Filing Documents

• ms14935_424b2-10694.htm (424B2) — 172KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 62KB
• image2.gif (GRAPHIC) — 77KB
• 0001839882-26-016785.txt ( ) — 467KB
• ex-filingfees_htm.xml (XML) — 2KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities provide for only the minimum payment at maturity and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they provide for only the minimum payment at maturity and do not pay interest. If the final level is less than the buffer level, the payout at maturity will be an amount in cash that is less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the underlier over the term of the securities beyond the buffer amount . You could lose a significant portion of your initial investment in the securities. The appreciation potential of the securities is limited by the maximum payment at maturity. Where the final level is greater than the initial level, the appreciation potential of the securities is limited by the maximum payment at maturity. If the underlier appreciates over the term of the securities, under no circumstances will the payment at maturity exceed the maximum payment at maturity. The amount payable on the securities is not linked to the value of the underlier at any time other than the observation date. The final level will be based on the closing level of the underlier on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of the underlier appreciates prior to the observation date but then drops by the observation date, the payment at maturity may be less, and may be significantly less, than it would have been ha

View Full Filing

View this 424B2 filing on SEC EDGAR